A pt, (b)(6) was enrolled in the (b)(4) study for stress urinary incontinence.On (b)(6) 2011, the pt was injected with 2.0 ml coaptite, lot 1019799.On (b)(6) 2013, the pt developed urinary tract infection identified by urinalysis.On (b)(6) 2013, the pt was treated with antibiotic keflex 500 mg po 07 days and cefdinir 300 mg po 7 days.The adverse event resolved on (b)(6) 2013.Per physician, the event was of mile severity and probably not related to coaptite.On (b)(6) 2013, the pt developed urinary tract infection identified by urinalysis.On (b)(6) 2013 the pt was treated with antibiotic 300mg po bid x 10 days and foley catheterization.The adverse event resolved on (b)(6) 2013.Per physician, the event was of mild severity and probably not related to coaptite.
|